These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23180018)

  • 1. VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy.
    Jin G; Zhou Y; Chai Q; Zhu G; Xu F; Liu F
    J Cancer Res Clin Oncol; 2013 Mar; 139(3):475-83. PubMed ID: 23180018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model.
    Fei S; Qi X; Kedong S; Guangchun J; Jian L; Wei Q
    J Cancer Res Clin Oncol; 2012 Feb; 138(2):347-57. PubMed ID: 22139383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enhanced efficacy of herpes simplex virus by lentivirus mediated VP22 and cytosine deaminase gene therapy against glioma.
    Mi R; Fan W; Ji J; Dong C; Jin G; Liu F
    Brain Res; 2020 Sep; 1743():146898. PubMed ID: 32439343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma.
    Kim JH; Kim JY; Kim SU; Cho KG
    Biochem Biophys Res Commun; 2012 Jan; 417(1):534-40. PubMed ID: 22177952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
    Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
    Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus-mediated CD/TK fusion gene transfection neural stem cell therapy for C6 glioblastoma.
    Niu J; Xing C; Yan C; Liu H; Cui Y; Peng H; Chen Y; Li D; Jiang C; Li N; Yang H
    Tumour Biol; 2013 Dec; 34(6):3731-41. PubMed ID: 23828263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit.
    Lee KC; Hamstra DA; Bullarayasamudram S; Bhojani MS; Moffat BA; Dornfeld KJ; Ross BD; Rehemtulla A
    Gene Ther; 2006 Jan; 13(2):127-37. PubMed ID: 16163381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene.
    Wybranietz WA; Gross CD; Phelan A; O'Hare P; Spiegel M; Graepler F; Bitzer M; Stähler P; Gregor M; Lauer UM
    Gene Ther; 2001 Nov; 8(21):1654-64. PubMed ID: 11895004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor efficacy of VP22-CD/5-FC suicide gene system mediated by lentivirus in a murine uveal melanoma model.
    Liu S; Song W; Liu F; Zhang J; Zhu S
    Exp Eye Res; 2018 Jul; 172():144-151. PubMed ID: 29660328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VP22 enhances the expression of glucocerebrosidase in human Gaucher II fibroblast cells mediated by lentiviral vectors.
    Jin GS; Zhu GD; Zhao ZG; Liu FS
    Clin Exp Med; 2012 Sep; 12(3):135-43. PubMed ID: 21874584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.
    Portnow J; Synold TW; Badie B; Tirughana R; Lacey SF; D'Apuzzo M; Metz MZ; Najbauer J; Bedell V; Vo T; Gutova M; Frankel P; Chen M; Aboody KS
    Clin Cancer Res; 2017 Jun; 23(12):2951-2960. PubMed ID: 27979915
    [No Abstract]   [Full Text] [Related]  

  • 12. Fusion of HSV-1 VP22 to a bifunctional chimeric SuperCD suicide gene compensates for low suicide gene transduction efficiencies.
    Lemken ML; Graepler F; Wolf C; Wybranietz WA; Smirnow I; Schmidt U; Gregor M; Bitzer M; Lauer UM
    Int J Oncol; 2007 May; 30(5):1153-61. PubMed ID: 17390017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma.
    Kosaka H; Ichikawa T; Kurozumi K; Kambara H; Inoue S; Maruo T; Nakamura K; Hamada H; Date I
    Cancer Gene Ther; 2012 Aug; 19(8):572-8. PubMed ID: 22744211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors.
    Lai Z; Han I; Zirzow G; Brady RO; Reiser J
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11297-302. PubMed ID: 11027330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered cell therapy for sustained local myocardial delivery of nonsecreted proteins.
    Bian J; Kiedrowski M; Mal N; Forudi F; Penn MS
    Cell Transplant; 2006; 15(1):67-74. PubMed ID: 16700331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural stem cell-based dual suicide gene delivery for metastatic brain tumors.
    Wang C; Natsume A; Lee HJ; Motomura K; Nishimira Y; Ohno M; Ito M; Kinjo S; Momota H; Iwami K; Ohka F; Wakabayashi T; Kim SU
    Cancer Gene Ther; 2012 Nov; 19(11):796-801. PubMed ID: 23018623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
    Xiong F; Xiao S; Peng F; Zheng H; Yu M; Ruan Y; Li W; Shang Y; Zhao C; Zhou W; Chen H; Chamberlain JS; Fang L; Zhang C
    Hum Gene Ther; 2007 Jun; 18(6):490-501. PubMed ID: 17550336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
    Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
    J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells.
    Ropper AE; Zeng X; Haragopal H; Anderson JE; Aljuboori Z; Han I; Abd-El-Barr M; Lee HJ; Sidman RL; Snyder EY; Viapiano MS; Kim SU; Chi JH; Teng YD
    Neurosurgery; 2016 Sep; 79(3):481-91. PubMed ID: 26671631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma.
    Ito S; Natsume A; Shimato S; Ohno M; Kato T; Chansakul P; Wakabayashi T; Kim SU
    Cancer Gene Ther; 2010 May; 17(5):299-306. PubMed ID: 19893595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.